Systematic Financial Management LP boosted its stake in shares of ICU Medical Inc. (NASDAQ:ICUI) by 2.5% during the second quarter, Holdings Channel reports. The fund owned 17,335 shares of the company’s stock after buying an additional 430 shares during the period. Systematic Financial Management LP owned about 0.11% of ICU Medical worth $1,954,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Renaissance Technologies LLC increased its stake in shares of ICU Medical by 3.6% in the first quarter. Renaissance Technologies LLC now owns 842,000 shares of the company’s stock valued at $87,652,000 after buying an additional 29,200 shares in the last quarter. GW&K Investment Management LLC increased its stake in shares of ICU Medical by 0.5% in the second quarter. GW&K Investment Management LLC now owns 542,184 shares of the company’s stock valued at $61,131,000 after buying an additional 2,798 shares in the last quarter. Silvercrest Asset Management Group LLC increased its stake in shares of ICU Medical by 14.8% in the first quarter. Silvercrest Asset Management Group LLC now owns 512,923 shares of the company’s stock valued at $53,396,000 after buying an additional 65,978 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of ICU Medical by 69.3% in the second quarter. Victory Capital Management Inc. now owns 366,618 shares of the company’s stock valued at $41,336,000 after buying an additional 150,066 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of ICU Medical by 67.5% in the second quarter. JPMorgan Chase & Co. now owns 309,998 shares of the company’s stock valued at $34,953,000 after buying an additional 124,920 shares in the last quarter. 89.50% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Inc. (NASDAQ:ICUI) traded down 0.01% on Monday, reaching $122.29. 26,094 shares of the company were exchanged. The stock has a market capitalization of $1.97 billion, a P/E ratio of 36.42 and a beta of 0.49. ICU Medical Inc. has a 12-month low of $85.56 and a 12-month high of $128.93. The company’s 50-day moving average price is $122.38 and its 200-day moving average price is $108.42.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Monday, August 8th. The company reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.10. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. The firm had revenue of $96.70 million for the quarter, compared to analyst estimates of $89.66 million. During the same period in the previous year, the firm posted $0.97 EPS. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. Equities research analysts anticipate that ICU Medical Inc. will post $4.54 earnings per share for the current fiscal year.

Several brokerages have recently issued reports on ICUI. Piper Jaffray Cos. reissued a “neutral” rating and set a $119.00 price objective (up previously from $115.00) on shares of ICU Medical in a research report on Thursday, August 11th. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price objective for the company in a research report on Friday, August 12th.

In other news, VP Steven Riggs sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 29th. The shares were sold at an average price of $110.00, for a total value of $2,200,000.00. Following the transaction, the vice president now owns 21,378 shares in the company, valued at approximately $2,351,580. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 1,903 shares of the business’s stock in a transaction that occurred on Monday, September 12th. The stock was sold at an average price of $121.29, for a total transaction of $230,814.87. Following the completion of the transaction, the vice president now owns 3,049 shares in the company, valued at approximately $369,813.21. The disclosure for this sale can be found here. Company insiders own 15.90% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

5 Day Chart for NASDAQ:ICUI

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.